After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...
10hon MSN
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...
A RETROSPECTIVE study conducted by Mass General Brigham researchers has found that taking semaglutide before bariatric ...
The commercial success of the injectable peptide-based weight-loss drugs marketed by Novo Nordisk and Eli Lilly and Company ...
5d
Interesting Engineering on MSNAI finds natural peptide that matches Ozempic’s weight loss power without side effectsStanford researchers have discovered BRP, a naturally occurring peptide that suppresses appetite and promotes weight loss, ...
6d
Verywell Health on MSN9 Supplements That Claim to Speed Up Weight Loss—But Do They Work?Weight loss supplements are a big industry, but do they actually work? A dietitian explores the evidence, efficacy, and safety of common weight loss supplements.
3don MSN
How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about Ozempic's and Mounjarno's patent cliffs. The scenarios in which Novo ...
Hims & Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the public ...
Some people have critiqued Ozempic (semaglutide)—a diabetes medication that can aid in weight loss—for the effects ... Collagen supplements for aging and wrinkles: A paradigm shift in the ...
2d
GlobalData on MSNViking strikes $150m deal to secure supply of obesity drugViking Therapeutics has inked a $150m multi-year manufacturing deal with CordenPharma to secure the future supply of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results